Healthcare is changing every day, and AmritaGen is pioneering the discovery of a new gene therapy for treating neurodegenerative diseases. Dr. James Simpkins is the CEO of AmritaGen, a company seeking to rebuild brain circuits and stimulate neurological activity in people with mild cognitive impairment. This therapy method can be utilized for delivering drug treatments for Alzheimer’s disease (AD), sporadic AD (sAD), Parkinson’s disease, stroke, and Traumatic Brain Injury. 

To learn more about AmritaGen, vist them at https://amritagen.com

To learn more about Innovate Fort Worth, visit https://innovatefortworthpodcast.com